Agent for suppressing a reduction of CD4.sup.+ lymphocytes

Details Agent for suppressing a reduction of CD4.sup.+ lymphocytes Agent for suppressing a reduction of CD4.sup.+ lymphocytes

1998-01-22

2000-08-01

Kemmerer, Elizabeth

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

Monoclonal antibody or fragment thereof

4241481, 4241541, 4241721, 4241391, 435332, A61K 39395, C07K 14525, C07K 1600

Patent

active

060963123

ABSTRACT:
An agent for preventing or treating AIDS which contains as its effective component an anti-Fas ligand antibody, and the method for preventing and treating AIDS by using such drug.

REFERENCES:
patent: 5436154 (1995-07-01), Barbeti et al.
patent: 5632994 (1997-05-01), Reed et al.
patent: 5750653 (1998-05-01), Chu et al.
Osband, Michael E. et al, Problems in the investigational study and clinical use of cancer immunotherapy, Immunology Today, vol. 11, No. 61990, pp. 193-195, 1990.
Okurma, Yasushi. Research Report for 1997 Project for Promoting the AIDS Pharmaceuticals Development with English Translation. No vol, Journal or Pages cited.
Yang, Yili. Blood, vol. 89, No. 2, Jan. 15, 1997; pp. 550-557.
Estaquier, Jerome. Blood, vol. 87, No. 12, Jun. 15, 1996; pp. 4959-4966.
Kovacs, Joseph A., M.D. New England Journal of Medicine, vol. 332, No. 9, 1995; pp. 567-575.

Affiliated with

Also associated with

Rating

Agent for suppressing a reduction of CD4.sup.+ lymphocytes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Agent for suppressing a reduction of CD4.sup.+ lymphocytes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agent for suppressing a reduction of CD4.sup.+ lymphocytes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-661022